V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10005657 | 10003530 | null | 58 | Adjuvant (A) | 2015-01-07 | 2015-01-12 | Rituximab | N | N | 10126144 | RITUXIMAB |
| 10005658 | 10003531 | 1.71 | 96.95 | null | 2014-05-10 | 2014-05-11 | Trastuzumab Subcutaneous | 2 | null | 10126144 | TRASTUZUMAB |
| 10005659 | 10003533 | 1.6 | 63 | Curative (C) | 2017-06-07 | 2017-06-21 | CHOP R - 21 days | N | N | 10141244 | CHOP R |
| 10005660 | 10003533 | 1.8 | 72.7 | Curative (C) | 2016-12-09 | 2016-12-09 | Docetaxel 100mg/m2 (21 day) | N | N | 10141244 | DOCETAXEL |
| 10005661 | 10003533 | 1.68 | 78.8 | null | 2015-09-23 | 2015-09-23 | Rituximab | N | N | 10141244 | RITUXIMAB |
| 10005662 | 10003533 | 1.65 | 60.8 | Palliative (P) | 2014-10-03 | 2014-10-16 | Irinotecan + Modified De Gramont | 01 | N | 10141244 | IRINOTECAN + MDG |
| 10005663 | 10003533 | 1.8 | 116 | Disease modification (D) | 2013-05-22 | 2013-05-29 | Docetaxel | 01 | N | 10141244 | DOCETAXEL |
| 10005664 | 10003533 | 1.58 | 54.7 | Curative (C) | 2016-06-12 | 2016-06-16 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 10141244 | RITUXIMAB |
| 10005665 | 10003534 | 1.55 | 50.3 | Curative (C) | 2016-05-16 | 2016-05-24 | Oxaliplatin + Modified de Gramont | N | N | 10231909 | OXALIPLATIN + MDG |
| 10005666 | 10003535 | 1.81 | 68.9 | Adjuvant (A) | 2013-12-29 | 2014-01-02 | FLUOROURACIL + IRINOTECAN | N | N | 10254921 | IRINOTECAN + MDG |
| 10005667 | 10003537 | 1.72 | 59 | Adjuvant (A) | 2016-10-15 | 2016-10-20 | CAPECITABINE + OXALIPLATIN | 02 | N | 10258775 | CAPECITABINE + OXALIPLATIN |
| 10005668 | 10003538 | 1.67 | 0 | Palliative (P) | 2015-11-21 | 2015-11-21 | Docetaxel | 2 | N | 10268105 | DOCETAXEL |
| 10005669 | 10003538 | 1.84 | 104 | Palliative (P) | 2016-11-16 | 2016-11-19 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10268105 | PACLITAXEL |
| 10005670 | 10003539 | 1.79 | 84 | Palliative (P) | 2014-06-01 | 2014-06-02 | Trastuzumab 21 day maintenance | N | null | 10308313 | TRASTUZUMAB |
| 10005671 | 10003540 | 1.83 | 89.1 | Curative (C) | 2015-02-14 | 2015-03-07 | Oxaliplatin + Modified de Gramont | 02 | N | 10330566 | OXALIPLATIN + MDG |
| 10005672 | 10003540 | 1.75 | null | null | null | 2016-11-12 | Oxaliplatin + Modified de Gramont | N | N | 10330566 | OXALIPLATIN + MDG |
| 10005673 | 10003541 | null | 68.2 | Curative (C) | null | 2017-04-14 | CAPECITABINE + OXALIPLATIN | N | N | 10406386 | CAPECITABINE + OXALIPLATIN |
| 10005674 | 10003542 | 1.59 | null | Neo-adjuvant (N) | 2015-05-05 | 2015-05-28 | Rituximab | 02 | N | 10406386 | RITUXIMAB |
| 10005675 | 10003542 | 1.68 | 76.5 | Curative (C) | 2016-12-16 | 2016-12-24 | Oxaliplatin + Modified de Gramont | 02 | N | 10406386 | OXALIPLATIN + MDG |
| 10005676 | 10003542 | 1.56 | 68.6 | Palliative (P) | null | 2015-11-10 | CAPECITABINE + OXALIPLATIN | 2 | N | 10406386 | CAPECITABINE + OXALIPLATIN |
| 10005677 | 10003543 | 1.7 | 88 | Adjuvant (A) | null | 2015-07-17 | Oxaliplatin + Modified de Gramont | null | null | 10483135 | OXALIPLATIN + MDG |
| 10005678 | 10003546 | 1.7 | 91.3 | Not known (9) | null | 2016-01-13 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10484451 | RITUXIMAB |
| 10005679 | 10003546 | 1.78 | 100 | Palliative (P) | 2016-07-10 | 2017-06-08 | Docetaxel | N | N | 10484451 | DOCETAXEL |
| 10005680 | 10003546 | 1.53 | 58 | null | 2014-03-04 | 2014-03-22 | TRASTUZUMAB | N | N | 10484451 | TRASTUZUMAB |
| 10005681 | 10003546 | 1.66 | 73.7 | Adjuvant (A) | 2018-06-15 | 2018-06-26 | FLUOROURACIL + OXALIPLATIN | 2 | N | 10484451 | OXALIPLATIN + MDG |
| 10005682 | 10003547 | 1.56 | 72.7 | Curative (C) | 2016-06-07 | 2016-06-07 | Docetaxel | 02 | N | 10063201 | DOCETAXEL |
| 10005683 | 10003547 | 1.63 | 63 | Neo-adjuvant (N) | null | 2019-05-10 | Irinotecan + Modified De Gramont | 02 | null | 10063201 | IRINOTECAN + MDG |
| 10005684 | 10003550 | 1.83 | 74.9 | Curative (C) | 2016-05-01 | 2016-10-18 | Rituximab (Maintenance) | N | N | 10065955 | RITUXIMAB |
| 10005685 | 10003550 | null | 78.2 | Palliative (P) | 2015-12-18 | 2015-12-25 | Rituximab | 02 | N | 10065955 | RITUXIMAB |
| 10005686 | 10003551 | 1.68 | 67.8 | Unknown (U) | null | 2015-10-29 | PEMBROLIZUMAB | N | N | 10125702 | PEMBROLIZUMAB |
| 10005687 | 10003552 | null | 52 | Palliative (P) | 2015-05-03 | 2015-05-04 | CHOP R - 21 days | 02 | null | 10127559 | CHOP R |
| 10005688 | 10003553 | 1.7 | 82.699 | Curative (C) | 2016-03-19 | 2016-04-02 | Oxaliplatin + Modified de Gramont | N | N | 10127559 | OXALIPLATIN + MDG |
| 10005689 | 10003555 | 1.73 | 79 | Curative (C) | 2018-07-29 | 2018-07-29 | Rituximab | 02 | N | 10169147 | RITUXIMAB |
| 10005690 | 10003555 | 1.6 | 79.9 | Adjuvant (A) | 2016-10-29 | 2016-12-11 | Docetaxel 100mg/m2 (21 day) | 2 | N | 10169147 | DOCETAXEL |
| 10005691 | 10003556 | 1.58 | 63.4 | Adjuvant (A) | 2014-06-08 | 2014-06-14 | FLUOROURACIL + OXALIPLATIN | N | N | 10225397 | OXALIPLATIN + MDG |
| 10005692 | 10006930 | 1.59 | 73.7 | Palliative (P) | 2016-09-20 | 2016-09-26 | FLUOROURACIL + IRINOTECAN | N | N | 10229380 | IRINOTECAN + MDG |
| 10005693 | 10003557 | 1.68 | 81.2 | Palliative (P) | 2015-08-24 | 2015-08-26 | Paclitaxel 7 day | N | N | 10230501 | PACLITAXEL |
| 10005694 | 10003558 | 1.66 | 85 | Palliative (P) | null | 2015-08-23 | Docetaxel 75mg/m2 (21 day) | 2 | N | 10230548 | DOCETAXEL |
| 10005695 | 10003560 | 1.68 | 68.7 | Adjuvant (A) | 2016-11-25 | 2016-12-04 | Rituximab | N | N | 10230764 | RITUXIMAB |
| 10005696 | 10006932 | 1.72 | 79 | Palliative (P) | null | 2017-01-05 | Docetaxel | 99 | N | 10230850 | DOCETAXEL |
| 10005697 | 10006932 | 1.87 | null | Adjuvant (A) | 2015-04-22 | 2015-04-22 | Rituximab | N | N | 10230850 | RITUXIMAB |
| 10005698 | 10003561 | null | null | Palliative (P) | 2017-03-25 | 2017-03-27 | Trastuzumab Subcutaneous | N | N | 10231893 | TRASTUZUMAB |
| 10005699 | 10003562 | 1.7 | 74 | Palliative (P) | 2017-12-16 | 2018-08-12 | FLUOROURACIL + OXALIPLATIN | 2 | N | 10232404 | OXALIPLATIN + MDG |
| 10005700 | 10003562 | 1.59 | 64.2 | Palliative (P) | 2017-06-11 | 2017-06-13 | CHOP R - 21 days | N | N | 10232404 | CHOP R |
| 10005701 | 10008316 | 1.72 | 65.3 | Palliative (P) | 2017-01-15 | 2017-01-15 | Rituximab | N | N | 10233510 | RITUXIMAB |
| 10005702 | 10003563 | 1.77 | 68 | Curative (C) | 2018-12-09 | 2018-12-18 | Irinotecan + De Gramont | N | N | 10233659 | IRINOTECAN + MDG |
| 10005703 | 10003564 | 1.66 | 63.9 | Palliative (P) | 2017-09-07 | 2017-09-14 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 10234123 | RITUXIMAB |
| 10005704 | 10003565 | 1.61 | 79 | Palliative (P) | 2018-04-27 | 2018-05-10 | PACLITAXEL | N | N | 10234123 | PACLITAXEL |
| 10005705 | 10008317 | 1.85 | 64 | Neo-adjuvant (N) | 2018-08-20 | 2018-08-23 | Docetaxel 100mg/m2 (21 day) | N | N | 10234178 | DOCETAXEL |
| 10005706 | 10008317 | 1.7 | 74.2 | Curative (C) | 2016-10-28 | 2016-10-28 | PACLITAXEL | N | N | 10234178 | PACLITAXEL |